Type 2 diabetes treatment tirzepatide, which is sold under the brand name Mounjaro, awaits FDA approval as a weight-loss medication.
diabetes lose up to almost a quarter of their body weight, or 22%, after 17 months compared to a 2% weight loss with a placebo.by the FDA, helped patients lose an average of 12% of their initial body weight after 16 months compared to those who received placebo.
But tirzepatide also mimics a second hormone, called GIP, which may improve how the body breaks down sugar and fat in addition to reducing appetite,Jennifer Huber of North Port, Florida, has been taking Mounjaro for almost a year to treat her Type 2 diabetes. She was surprised to lose about 60 pounds.
Serious side effects of the drug include pancreatitis, low blood sugar, serious allergic reactions, kidney problems, vision changes and gallbladder problems,The recent research comparing tirzepatide and semaglutide also noted that the highest dose of tirzepatide came with the highest increased risk for nausea, vomiting and diarrhea, compared to the placebo group and those using semaglutide.Dr.
"These medications, while potent and highly effective for the treatment of weight, must be continued indefinitely, or weight recurrence is inevitable. They are a treatment, not a cure."The list price of Mounjaro is about $1,023 per fill, which is equal to a month’s supply or four injector pens, according to Eli Lilly.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mounjaro vs. Ozempic: How These Medications CompareMounjaro vs. Ozempic: How These Medications Compare
Read more »
SoftBank Corp to raise over $800 million via bond-type class sharesSoftBank Corp to raise over $800 million via bond-type class shares - Bloomberg News
Read more »
Dolphins become fourth team in NFL history to score 70 points: ‘Video game-type stuff’The Miami Dolphins are looking like the best team in the NFL through three weeks.
Read more »
Depression identified as 'contributing cause' of type 2 diabetes risk, says new study: 'Important' findingsNew research reveals that people with a history of depression are at a higher risk of developing type 2 diabetes. Emergency medicine physician Dr. Joe Whittington weighed in on the findings.
Read more »
| Carolyn Hax: How does an expectant mom control her inner ‘Type A zombie’?A parent-to-be wants to “let go, take it easier, have more fun,” in lieu of a stressful house hunt before the baby comes.
Read more »